
Empresa de fabricación farmacéutica MENA de 40 años

EBITDA
$6,279,944
Gross
$37,000,000
Global lower-middle market M&A Advisors
Countries in which we've closed transactions
Languages spoken by our Team
Total deals value
Global lower-middle market M&A Advisors
Countries in which we've closed transactions
Languages spoken by our Team
Total deals value
© 2025 MergersCorp M&A International.
is a global brand operating through a number of professional firms and constituent entities located throughout the world to provide M&A Advisory and other client related professional services. The Member Firms are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit us on our website https://mergerscorp.com/disclaimer. MergersCorp M&A International is not a registered broker-dealer under the U.S. securities laws.
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by MergersUS Inc. or any other third party regardless of whether such security, product or service is referenced in this website. Furthermore, nothing in this website is intended to provide tax, legal, or investment advice and nothing in this website should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction.MergersCorp M&A International franchising program is not offered to individuals or entities located in the United States
The franchising program is offered by MergersUK Limited a UK Company with registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom
Esta empresa de fabricación farmacéutica se fundó hace unos 40 años en Ammán, Jordania. Ostenta el referente regional en innovación con más de 70 patentes.Como resultado directo de esta innovación, las operaciones se d ...
Esta empresa de fabricación farmacéutica se fundó hace unos 40 años en Ammán, Jordania. Ostenta el referente regional en innovación con más de 70 patentes.
Como resultado directo de esta innovación, las operaciones se diversificaron fuera de la industria farmacéutica genérica tradicional al convertir plataformas tecnológicas maduras en subsidiarias con administración y recursos independientes.
1. Negocio farmacéutico genérico de marca principal.
2. Productos naturales a través de la filial.
3. Diagnóstico biotecnológico a través de la filial.
4. Nuevos excipientes y sistemas de administración de medicamentos a través de la subsidiaria.
Los productos cubren una amplia gama de categorías terapéuticas que incluyen los sistemas cardiovascular, gastrointestinal, sistema nervioso central, antiinfeccioso, endocrino, musculoesquelético, respiratorio, obstétrico, ginecológico y del tracto urinario, e inmunológico.
Ofrece más de 200 productos farmacéuticos que cubren las necesidades de consumidores y profesionales sanitarios. Estos productos incluyen tabletas, cápsulas, supositorios, jarabes y suspensiones, los cuales se fabrican de acuerdo con Buenas Prácticas de Manufactura (GMP). La empresa tiene una ventaja competitiva que la convierte en una de las principales empresas farmacéuticas, ya que sus productos son de alta “Calidad”.
Es reconocida como una de las mejores empresas de Medio Oriente especializada en el desarrollo y producción de productos médicos vegetales y herbarios a partir de extractos de plantas medicinales estandarizados, y ofrece más de 50 productos innovadores naturales y herbarios con operaciones comerciales en más de 20 países en todo el mundo.
Es un desarrollador y productor de productos sanitarios biotecnológicos patentados que se especializa en la producción.
is a global brand operating through a number of professional firms and constituent entities located throughout the world to provide M&A Advisory and other client related professional services. The Member Firms are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit us on our website https://mergerscorp.com/disclaimer. MergersCorp M&A International is not a registered broker-dealer under the U.S. securities laws.
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by MergersUS Inc. or any other third party regardless of whether such security, product or service is referenced in this website. Furthermore, nothing in this website is intended to provide tax, legal, or investment advice and nothing in this website should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction.MergersCorp M&A International franchising program is not offered to individuals or entities located in the United States
The franchising program is offered by MergersUK Limited a UK Company with registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom
This website is operated by MergersUS Inc a US Corporation with registered office at
Error: Formulario de contacto no encontrado.
Error: Formulario de contacto no encontrado.
Error: Formulario de contacto no encontrado.
Error: Formulario de contacto no encontrado.
Error: Formulario de contacto no encontrado.